The European & Developing Countries Clinical Trials Partnership (EDCTP) Knowledge Hub: developing an open platform for facilitating high-quality clinical research.

African research leaders Capacity development Research leadership Research methodology Research resources

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
07 May 2022
Historique:
received: 10 12 2021
accepted: 21 03 2022
entrez: 7 5 2022
pubmed: 8 5 2022
medline: 11 5 2022
Statut: epublish

Résumé

There is stark global inequity in health research in terms of where studies happen, who leads the research and the ultimate beneficiaries of the results generated. Despite significant efforts made, limited research ideas are conceptualised and implemented in low-resource settings to tackle diseases of poverty, and this is especially true in sub-Saharan Africa. There is strong evidence to show that the barriers to locally led research do not vary largely between disease, study type and location and can be largely solved by addressing these common gaps. The European & Developing Countries Clinical Trials Partnership (EDCTP) was established in 2003 as a European response to the global health crisis caused by the three main poverty-related diseases HIV, tuberculosis and malaria. EDCTP has established a model of long-term sustainable capacity development integrated into clinical trials which addresses this lack of locally led research in sub-Saharan Africa, supporting the development of individual and institutional capacity and research outputs that change the management, prevention and treatment of poverty-related and neglected infectious diseases across Africa. In recognition of emergent data on what the barriers and enablers are to long-term, sustainable capabilities to run studies, EDCTP formed a new collaboration with The Global Health Network (TGHN) in September 2017, with the aim to make a set of cross-cutting tools and resources to support the planning, writing and delivery of high-quality clinical trials available to research staff wherever they are in the world, especially those in low- and middle-income countries (LMICs) via TGHN platform. These new resources developed on the 'EDCTP Knowledge Hub' are those identified in the mixed method study described in this commentary as being key to addressing the gaps that the research community report as the most limiting elements in their ability to design and implement studies. The Knowledge Hub aims to make these tools freely available to any potential health research team in need of support and guidance in designing and running their own studies, particularly in low-resource settings. The purpose is to provide open access to the specific guidance, information and tools these teams cannot otherwise access freely. Ultimately, this will enable them to design and lead their own high-quality studies addressing local priorities with global alignment, generating new data that can change health outcomes in their communities.

Identifiants

pubmed: 35526046
doi: 10.1186/s13063-022-06311-y
pii: 10.1186/s13063-022-06311-y
pmc: PMC9077850
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

374

Informations de copyright

© 2022. The Author(s).

Références

PLoS Med. 2009 Nov;6(11):e1000143
pubmed: 19956792
Trials. 2019 Dec 9;20(1):686
pubmed: 31815652
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Nature. 2020 Jul;583(7816):333
pubmed: 32669692
BMJ Glob Health. 2019 Jul 22;4(4):e001550
pubmed: 31406588
Lancet Glob Health. 2018 Sep;6(9):e964
pubmed: 30103996
PLoS One. 2019 May 1;14(5):e0215509
pubmed: 31042776
PLoS Negl Trop Dis. 2015 Aug 11;9(8):e0003997
pubmed: 26262756
Hum Vaccin Immunother. 2018 Jan 2;14(1):14-16
pubmed: 29136388
J Am Med Inform Assoc. 2007 Jul-Aug;14(4):478-88
pubmed: 17460139
PLoS One. 2018 Sep 19;13(9):e0203156
pubmed: 30231044
BMJ Open. 2017 Oct 13;7(10):e017246
pubmed: 29030412

Auteurs

Samuel Driver (S)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK. samuel.driver@ndm.ox.ac.uk.

Shan Gray (S)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Welile Sikhondze (W)

National TB Control Program, Ministry of Health, Mbabane, Eswatini.

Ken Awuonda (K)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Helena Wilcox (H)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Alexis Segrt (A)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Lara Pandya (L)

European & Developing Countries Clinical Trials Partnership, The Hague, The Netherlands.

Johanna Roth (J)

European & Developing Countries Clinical Trials Partnership, The Hague, The Netherlands.

Michael Makanga (M)

European & Developing Countries Clinical Trials Partnership, The Hague, The Netherlands.

Trudie Lang (T)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH